Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
The recently published phase-3 clinical trials data of the drug donanemab, which targets amyloid plaque, have shown to reduce cognitive decline in AD patients, but also cause brain haemorrhage (bleeding) and edema (swelling) in some of these patients
High-glycemic foods (white bread, sweets, fast food) trigger inflammation and breakouts
Youll learn how these medications impact appetite, metabolism, and body compositionand how to help clients navigate side effects, maintain lean mass, and build sustainable habits
Can next-generation GLP-1 drugs help with healthy aging
Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes2021
US$ 28.20
US$ 20.27
US$ 20.10
US$ 29.22
